BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

551 related articles for article (PubMed ID: 16839877)

  • 1. Recent expansion of the telomeric complex in rodents: Two distinct POT1 proteins protect mouse telomeres.
    Hockemeyer D; Daniels JP; Takai H; de Lange T
    Cell; 2006 Jul; 126(1):63-77. PubMed ID: 16839877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pot1 deficiency initiates DNA damage checkpoint activation and aberrant homologous recombination at telomeres.
    Wu L; Multani AS; He H; Cosme-Blanco W; Deng Y; Deng JM; Bachilo O; Pathak S; Tahara H; Bailey SM; Deng Y; Behringer RR; Chang S
    Cell; 2006 Jul; 126(1):49-62. PubMed ID: 16839876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protection of telomeres 1 proteins POT1a and POT1b can repress ATR signaling by RPA exclusion, but binding to CST limits ATR repression by POT1b.
    Kratz K; de Lange T
    J Biol Chem; 2018 Sep; 293(37):14384-14392. PubMed ID: 30082315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Telomere protection by TPP1 is mediated by POT1a and POT1b.
    Kibe T; Osawa GA; Keegan CE; de Lange T
    Mol Cell Biol; 2010 Feb; 30(4):1059-66. PubMed ID: 19995905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional dissection of human and mouse POT1 proteins.
    Palm W; Hockemeyer D; Kibe T; de Lange T
    Mol Cell Biol; 2009 Jan; 29(2):471-82. PubMed ID: 18955498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Telomere protection by TPP1/POT1 requires tethering to TIN2.
    Takai KK; Kibe T; Donigian JR; Frescas D; de Lange T
    Mol Cell; 2011 Nov; 44(4):647-59. PubMed ID: 22099311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ssDNA fragments induce cell senescence by telomere uncapping.
    Tsolou A; Passos JF; Nelson G; Arai Y; Zglinicki Tv
    Exp Gerontol; 2008 Oct; 43(10):892-9. PubMed ID: 18778766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The G-quadruplex ligand telomestatin inhibits POT1 binding to telomeric sequences in vitro and induces GFP-POT1 dissociation from telomeres in human cells.
    Gomez D; O'Donohue MF; Wenner T; Douarre C; Macadré J; Koebel P; Giraud-Panis MJ; Kaplan H; Kolkes A; Shin-ya K; Riou JF
    Cancer Res; 2006 Jul; 66(14):6908-12. PubMed ID: 16849533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PTOP interacts with POT1 and regulates its localization to telomeres.
    Liu D; Safari A; O'Connor MS; Chan DW; Laegeler A; Qin J; Songyang Z
    Nat Cell Biol; 2004 Jul; 6(7):673-80. PubMed ID: 15181449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human protection of telomeres 1 (POT1) is a negative regulator of telomerase activity in vitro.
    Kelleher C; Kurth I; Lingner J
    Mol Cell Biol; 2005 Jan; 25(2):808-18. PubMed ID: 15632080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A balanced transcription between telomerase and the telomeric DNA-binding proteins TRF1, TRF2 and Pot1 in resting, activated, HTLV-1-transformed and Tax-expressing human T lymphocytes.
    Escoffier E; Rezza A; Roborel de Climens A; Belleville A; Gazzolo L; Gilson E; Duc Dodon M
    Retrovirology; 2005 Dec; 2():77. PubMed ID: 16354306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. POT1 as a terminal transducer of TRF1 telomere length control.
    Loayza D; De Lange T
    Nature; 2003 Jun; 423(6943):1013-8. PubMed ID: 12768206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. POT1b protects telomeres from end-to-end chromosomal fusions and aberrant homologous recombination.
    He H; Multani AS; Cosme-Blanco W; Tahara H; Ma J; Pathak S; Deng Y; Chang S
    EMBO J; 2006 Nov; 25(21):5180-90. PubMed ID: 17053789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TRF2-tethered TIN2 can mediate telomere protection by TPP1/POT1.
    Frescas D; de Lange T
    Mol Cell Biol; 2014 Apr; 34(7):1349-62. PubMed ID: 24469404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pot1b -/- tumors activate G-quadruplex-induced DNA damage to promote telomere hyper-elongation.
    Takasugi T; Gu P; Liang F; Staco I; Chang S
    Nucleic Acids Res; 2023 Sep; 51(17):9227-9247. PubMed ID: 37560909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Critically short telomeres in acute myeloid leukemia with loss or gain of parts of chromosomes.
    Swiggers SJ; Kuijpers MA; de Cort MJ; Beverloo HB; Zijlmans JM
    Genes Chromosomes Cancer; 2006 Mar; 45(3):247-56. PubMed ID: 16281260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Regulation of telomeres length: making the telomeres accessible?].
    Riou JF; Gomez D; Mergny JL; Guittat L; Paterski R; Chenais B; Morjani H; Trentesaux C
    Bull Cancer; 2005 Jan; 92(1):13-22. PubMed ID: 15811846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Senescence induced by altered telomere state, not telomere loss.
    Karlseder J; Smogorzewska A; de Lange T
    Science; 2002 Mar; 295(5564):2446-9. PubMed ID: 11923537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA self-recognition in the structure of Pot1 bound to telomeric single-stranded DNA.
    Lei M; Podell ER; Baumann P; Cech TR
    Nature; 2003 Nov; 426(6963):198-203. PubMed ID: 14614509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dysfunctional telomeres activate an ATM-ATR-dependent DNA damage response to suppress tumorigenesis.
    Guo X; Deng Y; Lin Y; Cosme-Blanco W; Chan S; He H; Yuan G; Brown EJ; Chang S
    EMBO J; 2007 Nov; 26(22):4709-19. PubMed ID: 17948054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.